Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management ; volume:143 ; number:3 ; year:2020 ; pages:217-231
Acta haematologica ; 143, Heft 3 (2020), 217-231
- Creator
-
Saußele, Susanne
Haverkamp, Wilhelm
Lang, Fabian Magnus Eugen
Koschmieder, Steffen
Kiani, Alexander
Jentsch-Ullrich, Kathleen
Stegelmann, Frank
Pfeifer, Heike
La Rosée, Paul
Gökbuget, Nicola
Rieger, Christina
Waller, Cornelius F.
Franke, Georg-Nikolaus
le Coutre, Philipp
Kirchmair, Rudolf
Junghanß, Christian
- DOI
-
10.1159/000501927
- URN
-
urn:nbn:de:101:1-2020061800011889704442
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Saußele, Susanne
- Haverkamp, Wilhelm
- Lang, Fabian Magnus Eugen
- Koschmieder, Steffen
- Kiani, Alexander
- Jentsch-Ullrich, Kathleen
- Stegelmann, Frank
- Pfeifer, Heike
- La Rosée, Paul
- Gökbuget, Nicola
- Rieger, Christina
- Waller, Cornelius F.
- Franke, Georg-Nikolaus
- le Coutre, Philipp
- Kirchmair, Rudolf
- Junghanß, Christian
Other Objects (12)
Novel approaches in myelofibrosis
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Novel approaches in myelofibrosis
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Novel approaches in myelofibrosis
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms